Serum levels of mannose-binding lectin in systemic sclerosis: A possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtype

European Journal of Dermatology

Volumn 24, Issue 1, 2014, Pages 123-125

  Akamata, Kaname ^a   Asano, Yoshihide ^a   Aozasa, Naohiko ^a   Noda, Shinji ^a   Taniguchi, Takashi ^a   Takahashi, Takehiro ^a   Ichimura, Yohei ^a   Toyama, Tetsuo ^a   Sumida, Hayakazu ^a   Kuwano, Yoshihiro ^a   Yanaba, Koichi ^a   Tada, Yayoi ^a   Sugaya, Makoto ^a   Kadono, Takafumi ^a   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; AUTOIMMUNE DISEASE; CALCINOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL DYSMOTILITY; ESOPHAGUS DISEASE; FEMALE; HUMAN; IMMUNE RESPONSE; LETTER; MAJOR CLINICAL STUDY; MALE; MODIFIED RODNAN TOTAL SKIN THICKNESS SCORE; PROTEIN EXPRESSION; RAYNAUD PHENOMENON; SCORING SYSTEM; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TELANGIECTASIA; AGED; BLOOD; MIDDLE AGED; SCLERODERMA, DIFFUSE;

ADULT; AGED; FEMALE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; SCLERODERMA, DIFFUSE; SCLERODERMA, SYSTEMIC;

EID: 84897511948     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2245     Document Type: Letter

References (10)

1. York MR. Novel insights on the role of the innate immune system in systemic sclerosis. Expert Rev Clin Immunol 2011; 7: 481-9.
2. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005; 35: 548-55.
3. Kilpatrick DC, Stewart K, Allan EK, McLintock LA, Holyoake TL, Turner ML. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 2005; 35: 179-81.
4. Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC. Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology 2011; 21: 271-82.
5. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-6.
6. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437-44.
7. Bhattacharyya S, Kelley K, Melichian DS, et al. Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-α Responses: A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma. Am J Pathol 2013; 182: 192-205.
8. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11: 1173-9.
9. Yoshizaki A, Iwata Y, Komura K, et al. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 2008; 172: 1650-63.
10. Wang M, Chen Y, Zhang Y, Zhang L, Lu X, Chen Z. Mannanbinding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cell Mol Immunol 2011; 8: 265-75.